ImmunoPrecise Antibodies Ltd. IPA
1.62 0.00 0.00%
As of Oct 20, 2:54 PM ET
- Open
- 1.65
- Prev close
- 1.62
- Mkt cap
- 74.77M
- Vol
- 55.66K
- Avg vol
- 1.83M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.56
- High
- 1.65
- Forward P/E
- -2.49
- Beta
- 0.27
- Short ratio
- 0.70
- Inst. own
- 6.58%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 16, 2024
- 50-d avg
- 0.452
- 200-d avg
- 0.882795
- 1y target
- 5.00
YTD chart
Chart tools
Chart is warming up
The year-to-date price history for IPA has not been loaded yet. Try again in a moment.
Altman Z-Score
-1.07 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -7.0×
P/S 8.7×
P/B 9.0×
P/FCF -29.5×
EV/EBITDA -7.5×
EV/Sales 8.8×
FCF Yield -3.4%
Gross Margin 55.3%
Operating Margin -49.7%
Net Margin -123.3%
ROE -128.0%
ROIC -27.9%
ROA -68.0%
Revenue 0.0%
Operating Income 11.4%
EPS (diluted) 14.2%
Free Cash Flow -27.8%
Current Ratio 2.1×
Quick Ratio 1.8×
Debt / Equity 0.6×
Net Debt / EBITDA -0.1×
Interest Coverage -41.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-04-30